TY - JOUR AU - Okuda, Katsuhiro AU - Haneda, Hiroshi AU - Yokota, Keisuke AU - Tatematsu, Tsutomu AU - Nakanishi, Ryoichi PY - 2018 TI - The effect of smoking and TP53 mutations on molecular-targeted therapy in lung adenocarcinoma patients JF - Journal of Thoracic Disease; Vol 10, Supplement 33 (November 27, 2018): Journal of Thoracic Disease Y2 - 2018 KW - N2 - The treatment of non-small cell lung cancer (NSCLC) reached a major turning point with the discovery of gefitinib as an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) and the identification of EGFR mutations in 2004 (1). UR - https://jtd.amegroups.org/article/view/24127